Preliminary Final Report (Including Appendix 4E)
Filed with ASX · · 242 pages · English
In the deck
Story so far
Earlier from Mesoblast
- MSB Strengthens US Patent Portfolio For Rheumatic Diseases
- Mesoblast P2 Results Show Dose-Related Improvements In RA
- MSB Back Pain Results Presented, Receive Best Science Award
- Update on Heart Failure Trial and Funding of Operations
- Update on Global Heart Failure Program
Later from Mesoblast
- Mesoblast Phase 2 Diabetic Kidney Disease Results Published
- MSB Japan Strategy Highlighted At Business Council Meeting
- Successful Interim Futility Analysis In P3 Trial for GVHD
- First Quarter Results On Form 6K
- MD Anderson and NIH Fund Trial Using Mesoblast Technologies
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast